Successful Treatment of Severe Refractory Atopic Dermatitis with Efalizumab
November 2006 | Volume 5 | Issue 10 | Case Reports | 994 | Copyright © November 2006
Arta Farshidi BS, Parrish Sadeghi MD
Despite multiple therapeutic modalities, treatment of atopic dermatitis with its chronic, relapsing nature remains a challenge.
Chronic use of standard therapies is associated with variable efficacy and potential side effects. Targeted therapeutic
approaches using biologic agents may prove to be a novel alternative. We present a case of severe recalcitrant atopic dermatitis
successfully treated with efalizumab.